Amgen Appoints Senior VP of Business Development

By Pharma News - DCAT Publisher

March 14, 2014

Amgen has appointed David Piacquad to the new position of senior vice-president, business development. Piacquad will report directly to Robert A. Bradway, chairman and chief executive officer and will be responsible for business development across Amgen. Piacquad leads a new organization that combines the previously separate Corporate Development and External Research & Development groups.


Piacquad joined Amgen in June 2010 as vice-president, strategy & corporate development, bringing 26 years of business development and related experience. He joined Schering-Plough Corporation in 2006, reaching the level of senior vice-president, business development & licensing. He joined Johnson & Johnson in 1984, holding a series of leadership roles in finance and business development.

Source: Amgen